Exocrine Pancreatic Insufficiency Clinical Trial
Official title:
A Phase 1 Open-Label, Multicenter Study to Assess the Safety and Efficacy of ANG003 in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
Randomized, parallel, active-treatment Phase 1 study of a single dose of orally administered ANG003 with a test meal in adult subjects with cystic fibrosis-related exocrine pancreatic insufficiency. The study's overall objectives are to evaluate the safety, tolerability and effect of four dose levels of ANG003.
The Phase 1 study was designed to compare a 24h Baseline Substrate Absorption Challenge Test (SACT) period with no enzymes to a 24h ANG003 SACT period with enzymes. Eligible subjects will be randomly assigned with equal allocation to one of four active dose levels of lipase, protease and amylase. Approximately 48 to 60 eligible subjects are planned to be enrolled in the study with 12 to 15 subjects assigned to each dose level from up to 21 investigational sites. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02823964 -
EASY: Extended Access to Sollpura Over Years
|
Phase 4 | |
| Completed |
NCT02563080 -
Pancreatic Exocrine Insufficiency in Acute Pancreatitis
|
||
| Completed |
NCT01427725 -
Special Investigation of LipaCreon on Long-term Use in Patients With Pancreatic Exocrine Insufficiency
|
||
| Completed |
NCT01430234 -
Enzyme Suppletion in Exocrine Pancreatic Dysfunction
|
Phase 4 | |
| Completed |
NCT05082051 -
Oral CDX-7108 in Healthy Adults and EPI Subjects
|
Phase 1 | |
| Completed |
NCT03236038 -
Prevalence of Exocrine Pancreatic Insufficiency in Patients With Decompensated Cirrhosis
|
||
| Completed |
NCT03407534 -
Detection of Exocrine Pancreatic Insufficiency in Patients With Diarrhea and Bloating
|
||
| Completed |
NCT02598128 -
Safety, Tolerability and Fat Absorption Using Enteral Feeding In-line Enzyme Cartridge (Relizorb)
|
N/A | |
| Completed |
NCT00559364 -
Safety and Efficacy Study of Viokase® 16 for the Correction of Steatorrhea
|
Phase 3 | |
| Completed |
NCT00408317 -
Safety and Efficacy Study of ULTRASE® MT20 in Participants With Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (PI)
|
Phase 3 | |
| Recruiting |
NCT04548778 -
BÜHLMANN fPELA in the Diagnosis of Exocrine Pancreatic Insufficiency
|
||
| Completed |
NCT00449878 -
Liprotamase Efficacy Trial in Patients With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
|
Phase 3 | |
| Completed |
NCT00297167 -
Study to Evaluate the Safety and Efficacy of EUR-1008 (APT-1008) Pancreatic Enzyme Product in Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency
|
Phase 3 | |
| Completed |
NCT00981214 -
Study of Pancreatic Enzyme Product in Pediatric Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency
|
Phase 3 | |
| Recruiting |
NCT05480241 -
Exocrine Pancreatic Insufficiency After Acute Pancreatitis and Pancreatic Enzyme Replacement Therapy
|
N/A | |
| Recruiting |
NCT05261997 -
Endotherapy for Painless Chronic Pancreatitis
|
N/A | |
| Completed |
NCT02370537 -
A Study to Investigate How Common Pancreatic Exocrine Insufficiency (PEI) is in Patients With Type 2 Diabetes and Also to Investigate the Uptake of a Single Dose of EPANOVA® or OMACOR® in Patients With Different Degrees of PEI
|
Phase 2 | |
| Completed |
NCT00559052 -
An Open-Label Study to Evaluate the Intraduodenal Delivery of Enzymes From Administration of VIOKASE16 in Exocrine Pancreatic Insufficiency (EPI)
|
Phase 2 | |
| Recruiting |
NCT04112836 -
Pancreatic Cancer Malnutrition and Pancreatic Exocrine Insufficiency in the Course of Chemotherapy in Unresectable Pancreatic Cancer
|
||
| Completed |
NCT06278272 -
AI Evaluation of Pancreatic Exocrine Insufficiency in CP Patients
|